Literature DB >> 1644915

Bronchodilator action of inhaled nitric oxide in guinea pigs.

P M Dupuy1, S A Shore, J M Drazen, C Frostell, W A Hill, W M Zapol.   

Abstract

The effects of inhaling nitric oxide (NO) on airway mechanics were studied in anesthetized and mechanically ventilated guinea pigs. In animals without induced bronchoconstriction, breathing 300 ppm NO decreased baseline pulmonary resistance (RL) from 0.138 +/- 0.004 (mean +/- SE) to 0.125 +/- 0.002 cmH2O/ml.s (P less than 0.05). When an intravenous infusion of methacholine (3.5-12 micrograms/kg.min) was used to increase RL from 0.143 +/- 0.008 to 0.474 +/- 0.041 cmH2O/ml.s (P less than 0.05), inhalation of 5-300 ppm NO-containing gas mixtures produced a dose-related, rapid, consistent, and reversible reduction of RL and an increase of dynamic lung compliance. The onset of bronchodilation was rapid, beginning within 30 s after commencing inhalation. An inhaled NO concentration of 15.0 +/- 2.1 ppm was required to reduce RL by 50% of the induced bronchoconstriction. Inhalation of 100 ppm NO for 1 h did not produce tolerance to its bronchodilator effect nor did it induce substantial methemoglobinemia (less than 2%). The bronchodilating effects of NO were additive with the effects of inhaled terbutaline, irrespective of the sequence of NO and terbutaline administration. Inhaling aerosol generated from S-nitroso-N-acetylpenicillamine also induced a rapid and profound decrease of RL from 0.453 +/- 0.022 to 0.287 +/- 0.022 cmH2O/ml.s, which lasted for over 15 min in guinea pigs broncho-constricted with methacholine. Our results indicate that low levels of inhaled gaseous NO, or an aerosolized NO-releasing compound are potent bronchodilators in guinea pigs.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1644915      PMCID: PMC443117          DOI: 10.1172/JCI115877

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

1.  The kinetics and equilibria of the reactions of nitric oxide with sheep haemoglobin.

Authors:  Q H GIBSON; F J ROUGHTON
Journal:  J Physiol       Date:  1957-05-23       Impact factor: 5.182

2.  Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction.

Authors:  C Frostell; M D Fratacci; J C Wain; R Jones; W M Zapol
Journal:  Circulation       Date:  1991-06       Impact factor: 29.690

3.  Endothelium-derived nitric oxide relaxes nonvascular smooth muscle.

Authors:  G M Buga; M E Gold; K S Wood; G Chaudhuri; L J Ignarro
Journal:  Eur J Pharmacol       Date:  1989-02-14       Impact factor: 4.432

4.  Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosoamine.

Authors:  C A Gruetter; B K Barry; D B McNamara; D Y Gruetter; P J Kadowitz; L Ignarro
Journal:  J Cyclic Nucleotide Res       Date:  1979

5.  Pharmacological differentiation of epithelium-derived relaxing factor from nitric oxide.

Authors:  M Munakata; Y Masaki; I Sakuma; H Ukita; Y Otsuka; Y Homma; Y Kawakami
Journal:  J Appl Physiol (1985)       Date:  1990-08

6.  Degradative enzymes modulate airway responses to intravenous neurokinins A and B.

Authors:  S A Shore; J M Drazen
Journal:  J Appl Physiol (1985)       Date:  1989-12

7.  Role of cyclic nucleotide phosphodiesterase isozymes in intact canine trachealis.

Authors:  T J Torphy; H L Zhou; M Burman; L B Huang
Journal:  Mol Pharmacol       Date:  1991-03       Impact factor: 4.436

8.  Nitric oxide as an endogenous modulator of cholinergic neurotransmission in guinea-pig airways.

Authors:  M G Belvisi; D Stretton; P J Barnes
Journal:  Eur J Pharmacol       Date:  1991-06-06       Impact factor: 4.432

9.  Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase.

Authors:  M Feelisch; E A Noack
Journal:  Eur J Pharmacol       Date:  1987-07-02       Impact factor: 4.432

10.  Inhaled nitric oxide. A selective pulmonary vasodilator of heparin-protamine vasoconstriction in sheep.

Authors:  M D Fratacci; C G Frostell; T Y Chen; J C Wain; D R Robinson; W M Zapol
Journal:  Anesthesiology       Date:  1991-12       Impact factor: 7.892

View more
  45 in total

Review 1.  Response to inhaled nitric oxide in premature and term neonates.

Authors:  T Hoehn; M F Krause
Journal:  Drugs       Date:  2001       Impact factor: 9.546

2.  Deficiency of nitric oxide in allergen-induced airway hyperreactivity to contractile agonists after the early asthmatic reaction: an ex vivo study.

Authors:  J de Boer; H Meurs; W Coers; M Koopal; A E Bottone; A C Visser; W Timens; J Zaagsma
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

3.  Inhaled nitric oxide effects on lung structure and function in chronically ventilated preterm lambs.

Authors:  Richard D Bland; Kurt H Albertine; David P Carlton; Amy J MacRitchie
Journal:  Am J Respir Crit Care Med       Date:  2005-06-23       Impact factor: 21.405

4.  Inhaled nitric oxide therapy in adults: European expert recommendations.

Authors:  Peter Germann; Antonio Braschi; Giorgio Della Rocca; Anh Tuan Dinh-Xuan; Konrad Falke; Claes Frostell; Lars E Gustafsson; Philippe Hervé; Philippe Jolliet; Udo Kaisers; Hector Litvan; Duncan J Macrae; Marco Maggiorini; Nandor Marczin; Bernd Mueller; Didier Payen; Marco Ranucci; Dietmar Schranz; Rainer Zimmermann; Roman Ullrich
Journal:  Intensive Care Med       Date:  2005-06-23       Impact factor: 17.440

5.  Successful use of inhaled nitric oxide for severe hypoxemia in an infant with acute exacerbation of bronchiolitis due to sepsis.

Authors:  K Okamoto; T Tashima; I Kukita; T Sato; M Kurose; K Taki
Journal:  J Anesth       Date:  1995-03       Impact factor: 2.078

Review 6.  Delivery and monitoring of inhaled nitric oxide.

Authors:  J D Young; O J Dyar
Journal:  Intensive Care Med       Date:  1996-01       Impact factor: 17.440

Review 7.  Pharmacology and potential therapeutic applications of nitric oxide-releasing non-steroidal anti-inflammatory and related nitric oxide-donating drugs.

Authors:  J E Keeble; P K Moore
Journal:  Br J Pharmacol       Date:  2002-10       Impact factor: 8.739

8.  Nitric oxide (NO) modulation of PAF-induced cardiopulmonary action: interaction between NO synthase and cyclo-oxygenase-2 pathways.

Authors:  F Fabi; R Calabrese; T Stati; P del Basso
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

9.  Effect of inhaled nitric oxide on intrapulmonary right-to-left-shunting in two rabbit models of saline lavage induced surfactant deficiency and meconium instillation.

Authors:  M F Krause; H G Lienhart; J Haberstroh; T Hoehn; J Schulte-Mönting; J U Leititis
Journal:  Eur J Pediatr       Date:  1998-05       Impact factor: 3.183

10.  Combined effects of NO inhalation and intravenous PGF2 alpha on pulmonary circulation and gas exchange in an ovine ARDS model.

Authors:  H Kobayashi; N Tanaka; M Winkler; W M Zapol
Journal:  Intensive Care Med       Date:  1996-07       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.